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primary patency were 84% and 90% respectively. Freedom
from reintervention at 1 year was 83%. Treatment was
associated with a sustained significant reduction in pain
(91% vs. 6%, P .001) and edema (97% vs. 12%, P
.001) at a mean follow-up of 29 months (range 5-83
months), at which time 89% of patients reported to be at
their baseline pre-DVT functional status with return to
work.
Conclusions: Aggressive therapy of symptomatic iliac
vein stenosis or occlusion with venography, catheter-
directed thrombolysis, and iliac vein stent placement pro-
vides durable patency and freedom from reintervention.
Most patients can anticipate good functional recovery with
decreased pain and edema and the capability to return to
their previous employment.
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Objectives: Defective venous valves are central to
chronic venous insufficiency. A simple method of en-
dovenous valve transfer to replace normal competent
valves for defective ones would appear to be a beneficial
concept. An essential pre-requisite was the development
of an venous valve transfer stent with associated deliver
system.
Methods:The internal jugular veins of sheep 45-55kgs
were used (n16). A segment of vein with valve were
stented externally to a specially designed stent. The stent
was introduced remotely into a contralateral internal jugu-
lar venotomy. Harvesting occurred acutely (n1) and at 1,
3 and 6 months post-operatively (n5 per group). In vivo
competence testing macroscopic, microscopic and scan-
ning electron microscopic (SEM) examinations were per-
formed. 4 humans (all male, mean age 52) were treated (6
valves), brachial to femoro-popliteal segment. All had
chronic ulcers and exhausted all treatments. Suitability for
for valve transfer was assessed using ultrasound and
venography.
Results: At harvest there was no evidence of throm-
bosis, tilting, endoleak or migration in any of the speci-
mens. There was improvement in competence with mac-
roscopic, microscopic and SEM findings. In the human
cases 2 ulcers had healed, one progressed and one re-
mained unchanged (FU 2yrs). There was one type I
venous endoleak.
Conclusions: Endovenous valve transfer is a simple
surgical technique with near perfect results in sheep. Very
specific stent design facilitates harvesting, improves compe-
tence and avoids complications. Further Human studies are
in progress.
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Objectives: Pregnancy is a major contributory factor in
the increased incidence of varicose veins in women, which
in the long term can lead to venous insufficiency and leg
oedema. Traditionally treatment is aimed at symptom re-
duction and is divided in three groups: surgery, pharmaco-
logical and non-pharmacological treatments. Advantages in
treatment of venous incompetence has been achieved by
exostent venous valve repair. The aim of this paper is to
assess the effect of pregnancy on exostent venous valve
repair at the SFJ, either with or without the subterminal
valve.
Methods: A total of 31 limbs subjected to 29 preg-
nancy (including twins) have been investigated using ultra-
sonography with assessment of the valve and valve mobility,
the cusps and whether there was incompetence. These
where subsequently treated and followed up for aminimum
of 2.3 years (mean 8.3, 3.8) in 18 women (mean age at
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time of surgery 34, 9), both clinically and ultrasonically.
Recurrences and additional venous treatments where
noted.
Results: The Australian National Medical database
indicates 3262 patients have had SFJ valve (with or
without the subterminal valve) repaired using exostents
for varicose veins. Recurrences have occured in 5 (16%)
of the 31 limbs in the valve stented limb. These were
treated with ultrasound guided sclerotherapy. Recurrent
SFJ incompetence was encountered in 4 (13%) patients.
None have required surgical intervention. Two of the
four limbs with incompetence of other venous systems
treated with venous ablation sustained recurrences.
Conclusions: Exostent venous valve repair at the SFJ
can withstand the haemodynamic stresses of a pregnancy.
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Objectives: Varicose vein (VV) patients suffer not
only from their symptoms but also from appearance. A
standardized method for assessing VV appearance from a
patient and clinician perspective is lacking. A study was
conducted to assess the performance of a clinician-
reported outcome (ClinRO) instrument and a patient-
reported outcome (PRO) instrument developed through
qualitative patient interviews for the evaluation of VV
appearance.
Methods: To assess the patient visible VV appearance
instrument (PA-V3) and an independent expert panel rat-
ing scale (IPR-V3) of standardized photographs, 40 pa-
tients with VVs were recruited at a single site, half of the
patients had treated saphenofemoral junction (SFJ) incom-
petence; the remainder were awaiting treatment. Patients
scored the appearance of their VV on a 0 to 4 “noticeabil-
ity” scale (0 not noticeable to 4 extremely noticeable,
PA-V3); this was repeated after 2 weeks. A physician scored
the VV on a 0 to 4 severity scale at the same visits.
Standardized photographs of the patient’s VV were
scored on a 0 to 4 severity scale (IPR-V3) by a panel of
independent trained expert physicians blinded to treat-
ment status. Measures were compared for reliability and
variability within and between each other and with other
known assessment tools (VEINES-QOL, CIVIQ-2, and
VCSS).
Results: Most patients were female (72%); mean age
was 50.7 years. Test/retest between assessments produced
matches to within 1 score of 87.5% and 100% for PA-V3
and IPR-V3, respectively. Both measures were found to
correlate well with each other (Pearson coefficient0.793)
and with the physician assessment and other standard as-
sessment tools (ranges from 0.758 to 0.881). As expected,
treated patients had notably lower scores for all
instruments.
Conclusions: PA-V3 and IPR-V3 are sensitive and
reproducible measures of VV appearance from the per-
spective of the clinician, the independent expert panel,
and the patient. These tools are suitable for measuring
change in appearance following VV intervention.
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Objectives: Vena cava filter (VCF) insertion is some-
times performed as a secondary procedure during opera-
tions unrelated to treatment of venous thromboembolism
(VTE). This approach has not been characterized and
limited evidence exists to support it.
Methods: VCF insertions were identified within the
2005-2010 American College of Surgeons National Surgi-
cal Quality Improvement (ACS-NSQIP) Participant Use
Datafile. Secondary VCF insertions, performed during
the same anesthetic as a primary procedure unrelated to
VTE treatment, were classified based on primary CPT
codes. Primary CPT codes were then used to compare
overall rates of secondary VCF insertion and postopera-
tive DVT.
Results: 364 patients met the inclusion criteria. Pri-
mary bariatric surgery procedures accounted for the
largest number of VCF insertions (N174) followed by
colon (N41), hepatobiliary (N14), peripheral vascu-
lar (N14), gastric (non-bariatric) (N13), and ampu-
tation (N10) procedures. Rates of VCF utilization
exceeded incidence of postoperative DVT for bariatric
(2.5 vs. 1.6/1000) and endocrine (3.5 vs. 3.0/1000)
procedures.
Conclusions: Secondary VCF insertion may be over-
utilized, particularly in prophylactic scenarios where
DVT risk is low. Further critical evaluation of VCF use is
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